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Abstract
Background: Kaposi sarcoma (KS) is a complex multifocal neoplasm and is the major cause of death for about
50% of acquired immunodeficiency syndrome (AIDS) patients. Kaposi’s sarcoma-associated herpesvirus (KSHV) is an
oncogenic virus with a causal role in the development of all types of KS. KS is prevalent among the Uygur people
in Xinjiang, especially in south area. Here we carried out a cross-sectional study among 1534 general Uygur
individuals from south and north region of Xinjiang to assess the seroprevalence of KSHV and to identify the
potential correlation between KSHV seroprevalence and KS incidence.
Results: Seroprevalence of KSHV in South and North Xinjiang was 23.1% and 25.9%, respectively. Older age was
independently associated with higher KSHV seroprevalence. In subjects from South Xinjiang, lower educational
level and reported drinking were each independently associated with higher KSHV seroprevalence. Furthermore,
the antibody titer was significantly lower in both south and north KSHV seropositive individuals compared with KS
patients, as analyzed by gradient dilution (P < 0.001).
Conclusion: KSHV is highly prevalent in the general Uygur population in both South and North Xinjiang.
Interestingly, the infection rate of KSHV in these two geographical areas did not correlate well with KS incidence.
Perhaps unknown factors exist that promote the progression of KSHV infection to KS development in the local
minority groups.
Keywords: Kaposi’s sarcoma-associated herpesvirus (KSHV), Kaposi’s sarcoma (KS), seroprevalence, Uygur people,
risk factors, Xinjiang
Background
Kaposi sarcoma (KS) is a mesenchymal tumour involving
blood and lymphatic vessels [1]. KS can be classified
according to its clinical and epidemiological characteris-
tics and the different types include: classical, acquired
immunodeficiency syndrome (AIDS)-related, iatrogenic
and endemic KS [2,3]. Notably, KS is the most common
cancer associated with AIDS worldwide [4]. Approxi-
mately 20% of AIDS patients develop KS in Western
countries and AIDS-KS is the major cause of death for
about 50% of AIDS patients [5,6]. Kaposi’s sarcoma-asso-
ciated herpesvirus (KSHV) also known as Human herpes-
virus 8 (HHV-8 ), is an oncogenic virus with a causal role
in the development of KS [2,7-9], and two other AIDS-
related lymphoproliferative disorders: primary effusion
lymphoma (PEL) and the plasma-cell variant of multi-
centric Castleman’s disease (MCD) [10]. KSHV has been
detected in the lesions of nearly all patients with KS
[11,12], and when detected in blood it is predictive of the
development of KS [8,13].
KSHV prevalence exhibits considerable variation in dif-
ferent geographical regions and populations. Several stu-
dies have demonstrated that KSHV seroprevalence
correlates with the occurrence of KS [14-17]. In most
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0% to 3%, which is consistent with a generally lower inci-
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China, KSHV seroprevalence was less than 8% [19,20].
However, the Xinjiang area, located northwest of China,
exhibited a distinct pattern. Over 95% of KS cases in
China occurred in Xinjiang, especially classic cases of KS
which predominantly occurred in minority groups, parti-
cularly in older men [21]. Recent studies have found
KSHV seroprevalence correlates with the high incidence
of KS in Xinjiang, which ranged from 12.5% to 48.0% in
different study populations, including the general popula-
tion, blood donors, tumor patients and HIV-infected
individuals [18,21-24]. The incidence of HIV infection
has increased rapidly in Xinjiang over the past few years.
Thus, increasing numbers of AIDS-KS cases have
recently been reported in this area. It is therefore of great
medical importance to investigate KSHV seroprevalence
and transmission mode-associated behaviors in Xinjiang,
to gain a greater epidemiological understanding of these
diseases, and to then be able to apply these findings to
improve public health strategies.
Xinjiang is located at the middle point of the Silk Road
that used to extend from Rome to China. Many ethnici-
ties, such as the Uygur (48%), Han (38%) and Kazakh
people (7%), mix in this area. Classical KS cases occur
most frequently in two of these minority groups: the
Uygur and Kazakh groups. Furthermore, about 90% of
KS cases have been reported in the Uygur group, which
reside in the south region of Xinjiang [21]. However, the
limitations of previous studies have been that they were
generally either restricted to Uygur patients or mainly
from the northern part of Xinjiang [18,21,22], where the
socio-economic status is higher than in other areas. The
objective of the current study was to investigate the
potential correlation between KSHV seroprevalence and
KS incidence in Xinjiang endemic areas, and to deter-
mine whether environmental or sanitation-associated
issues effect KSHV infection rates or KS incidence in this
ethnic background.
Results
Characteristics of the study population and KSHV
seroprevalence
Of the 1534 Uygur people included in the study, 1008
(65.7%) were from the southern part of Xinjiang and 526
(34.3%) were from the northern part of Xinjiang. The ser-
oprevalence of KSHV among the general Uygur popula-
tion in the southern and northern parts of Xinjiang was
23.1% and 25.9%, respectively. Table 1 presents the asso-
ciations with gender, age and education stratified by
region (Southern and Northern). The lower education
associated with KSHV seroprevalence only in south
region of Xinjiang.
A multivariate logistic regression analysis was used to
identify independent risk factors for KSHV infection in
total study population (Table 2). In this model, KSHV
was significantly more prevalent in individuals aged ≥55
years compared to those aged < 55 years. Moreover,
place of residence was also independently associated
with KSHV seroprevalence.
KSHV seropositivity among 1008 subjects from south
region of Xinjiang
The characteristics of the 1008 Uygur village participants
from Southern Xinjiang and the KSHV seroprevalence
rates are presented in Table 3. In this study population,
497 subjects were male (49.3%) and 511 were female
(50.7%). The age distribution was from 18 to 91 years old.
Among 39 subjects positive for hepatitis B and C viruses
(HBV and HCV), 11 were KSHV positive (28.2%). Interest-
ingly, participants who were regular drinkers exhibited
high serum prevalence of KSHV (46.2%). Table 3 illus-
trates the univariate associations between KSHV infection
and the 1008 participants characteristics. KSHV infection
was associated with advancing age (P = 0.020). More
Table 1 The associations of KSHV seroprevalence with gender, age and education stratified by geographic region
(Southern and Northern) in general Uygur subjects from Xinjiang, China
Characteristic Moyu country(Southern) Urumqi(Northern)
No.of Subjects KSHV seropositivity n(%) c
2 P No.of Subjects KSHV seropositivity n(%) c
2 P
Gender 0.337 0.562 0.411 0.521
Male 497 111(22.3) 287 71(24.7)
Female 511 122(23.8) 239 65(27.2)
Age (years) 2.768 0.096 0.446 0.504
< 40 584 124(21.2) 480 126(26.3)
≥40 424 109(25.7) 46 10(21.7)
Education (years) 6.632 0.010 2.340 0.126
≤6 720 182(25.3) 24 3(12.5)
> 6 288 51(17.7) 502 133(26.5)
Total 1088 233(23.1) 526 136(25.9)
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21.2% in those aged < 40 years to 21.3% in those aged
40-55, and to 30.7% in those aged ≥55 years. Furthermore,
there was a significant difference in KSHV seroprevalence
with respect to educational level (P = 0.020), from 17.7%
in those educated to junior high school level, to 24.3% in
those educated to elementary school level, and to 28.3% in
those who were illiterate/semiliterate. An association of
borderline significance was detected between KSHV sero-
positivity and the report of drinking (P = 0.058). No asso-
ciations were observed between KSHV infection and
gender, family number, BMI and HBV or HCV infection.
To further identify independent risk factors, variables
that were significant in univariate analysis at P = 0.100
were included in multivariate logistic regression analysis
and the data are presented in Table 4. Lower educational
level (Illiterate/semiliterate vs. Junior high school, OR =
1.67, 95% CI = 1.02-2.73) and reported drinking (yes vs.
Table 2 Multivariate logistic regression analysis:
determinants of KSHV seropositivity
Characteristic OR 95% CI P value
Gender
Male 1.00
Female 1.08 0.86-1.37 0.51
Age
< 40 0.69 0.47-1.03 0.07
40-55 0.63 0.41-0.96 0.03
≥ 55 1.00
Education level
Illiterate/semiliterate 1.44 0.89-2.30 0.13
Elementary school 1.26 0.90-1.76 0.18
Junior high school 1.00
region
Moyu country 1.00
Urumqi 1.49 1.07-2.08 0.02
Table 3 Univariate analysis of KSHV seroprevalence in the subjects from southern part of Xinjiang
Characteristic Uygur people n(%) KSHV seropositivity n(%) OR 95% CI P value
Gender
Male 497 111 (22.3) 1.00
Female 511 122 (23.8) 1.10 0.81-1.46 0.56
Age
< 40 584 124 (21.2) 1.00
40-55 225 48 (21.3) 1.01 0.69-1.47 0.98
≥55 199 61 (30.7) 1.64 1.14-2.35 0.01
Education level
Illiterate/semiliterate 180 51 (28.3) 1.00
Elementary school 540 131 (24.3) 0.81 0.55-1.18 0.28
Junior high school 288 51 (17.7) 0.54 0.35-0.85 0.01
Family number
≤5 people 641 151 (23.6) 1.00
> 5 people 367 82 (22.3) 0.93 0.69-1.27 0.66
Smoking
No 931 217 (23.3) 1.00
Yes 77 16 (20.8) 0.86 0.49-1.53 0.61
Drinking
No 995 227 (22.8) 1.00
Yes 13 6 (46.2) 2.90 0.97-8.72 0.06
HBV
Negative 983 226 (23.0) 1.00
Positive 25 7 (28.0) 1.30 0.54-3.16 0.56
HCV
Negative 994 229 (23.0) 1.00
Positive 14 4 (28.6) 1.34 0.42-4.30 0.63
BMI
≥25 330 73 (22.1) 1.00
< 25 678 160 (23.6) 0.92 0.67-1.26 0.60
Total 1008 233 (23.1)
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dently associated with higher KSHV seroprevalence.
Antibody titers of KSHV in highly seropositive individuals
and KS patients
The distribution pattern of KSHV antibody titers among
high seropositive individuals from both north and south
and KS patients were compared and the results are dis-
played in Figure 1. The individual number of low antibody
titer group in south, north and KS patients was 35,40 and
28. For medium group, the number is 5,0 and 11. How-
ever, the number is 0,0 and 12 in south, north and KS
patients for high group( c
2 = 33.74, P < 0.001).These
results indicated that compared with KS patients, KSHV-
infected individuals in both south and north presented a
lower antibody titer against KSHV.
Discussion
More than 95% of KS cases in China, including all epide-
miological forms, were observed in minority groups in
Xinjiang, particularly in the Uygur group [21]. Previous
studies have shown a high seroprevalence of KSHV in the
range of 12.5% to 48.0% in different study populations in
this region, that correlated well with a high incidence of
KS [18,21-23]. However, these studies were mainly
restricted to Uygur patients with diseases other than KS,
and the study populations were mainly from the northern
part of Xinjiang [18,21]. Thus the discrepancy between the
socio-economic status in these two geographical areas and
the absence of behavior-associated data, mean that these
studies did not take other variables into account. In the
current cross-sectional study, the seroprevalence of KSHV
among the general Uygur population in the southern and
northern parts of Xinjiang was 23.1% and 25.9%, respec-
tively, which is in agreement with previous findings from
Xinjiang [21-24]. There was no significant difference in
KSHV infection between the two regions of Xinjiang, indi-
cating that minority group background is still the most
important factor in KSHV infection. Although as expected,
titers were higher in KS cases than in the general popula-
tion, titers in the general population did not differ by geo-
graphy, unlike the incidence of KS which is much higher
in the South. Combined with the distribution pattern of
KSHV antibody titers among seropositive individuals and
KS patients, our findings suggested that other unknown
factors may exist in South Xinjiang which potentially pro-
mote the development from KSHV infecton during KS
pathogenesis. To further confirm this hypothesis, a pro-
spective study focused on geographical and ethnic para-
meters should be carried out.
The seroprevalence of KSHV in the general Uygur
population in Xinjiang was significantly more prevalent in
individuals aged ≥55 years compared to those aged < 55
years. These results are consistent with those of several
other studies, which described an increase in seropreva-
lence of KSHV with age in different populations [25-29].
This correlation may be related to the natural aging pro-
cess. Generally, the immunity of older people is weaker
than that of younger people, and hypoimmunity maybe a
promoting agent for KSHV infection. Moreover, it is nota-
ble that KSHV prevalence was similar in men and women
which is consistent with many studies [18,29]. and our
previous researches [21,23] that find the distribution of
KSHV seroprevalence has no difference by sex.
Further analyses were then carried out to focus on the
1008 rural Uygur people from South Xinjiang. This is the
first report regarding KSHV seroprevalence and risk fac-
tors in this area, a region endemic for KS. The seropreva-
lence of KSHV in this study population was independently
associated with educational level. It was apparent that with
improved educational level (from illiterate/semiliterate to
Junior high school level education), KSHV seroprevalence
decreased from 28.3% to 17.7%, suggesting that a higher
education level is a protection factor for KSHV infection.
Notably, the educational level of this study population was
usually below the high school level, and among the older
age group (≥55) the percentage of illiterate/semiliterate
Table 4 Independent risk factors for KSHV infection in
southern part of Xinjiang
Characteristic OR 95% CI P value
Age (years)
< 40 1.00
40-55 0.91 0.62-1.35 0.64
≥55 1.42 0.95-2.11 0.08
Education level
Junior high school 1.00
Elementary school 1.48 1.02-2.14 0.04
Illiterate/semiliterate 1.67 1.02-2.73 0.04
Drinking
No 1.00
Yes 3.23 1.07-9.78 0.04
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Figure 1 Distribution of KSHV antibody titers in KS patients
and seropositive samples from North and South Xinjiang.
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Page 4 of 7individuals was 43.7%. Therefore, knowledge about health
issues is far more limited in the Uygur population in this
region, especially in the elder Uygur population. Further-
more, the mobility of the population in this region is rela-
tively low. The traditional life style and behavior of the
Uygur people has remained unchanged over the past two
decades [30], with the life quality and level of education
reflecting their low socioeconomic status. Such conditions
might facilitate the transmission of KSHV infection, in line
with with previous reports linking KSHV to rural settings
in Italy and Sicily [31-33]. Interestingly, we also identified
drinking could increase the risk of KSHV infection, a
result consistent with previous studies [34,35]. Among 13
drinkers, six were KSHV positive (46.2%). Because of the
small sample size, the relationship between drinking and
KSHV infection requires further investigation in a larger
sample population in Xinjiang.
Conclusions
We identified a high seroprevalence of KSHV infection in
the general Uygur population in both South and North
Xinjiang, and the distribution of KSHV seroprevalence in
these two geographical areas did not show a clear correla-
tion with KS incidence. Perhaps other unknown factors
have promoted the association between KSHV infection
and KS development in the local minority groups. Under-
standing the epidemiology of KSHV infection in rural
areas of Uygur is critical for designing effective interven-
tion strategies to decrease the transmission of this virus
and to prevent malignancies associated with KSHV
infection.
Methods
Study participants
South Xinjiang was represented by Moyu Country of
Hotan City which is located in the southernmost region of
Xinjiang surrounding the Tarim Basin and where more
than 95% of the population were rural Uygur people.
North Xinjiang was represented by Urumqi, which is the
most highly developed and industrialized region in Xin-
jiang. A total of 1543 research subjects were randomly
selected from this two regions of Xinjiang by using a stra-
tified, multistage sampling. Among them, residents (age >
18years) from 15 villages in 3 rural town of Moyu Country
and employees from top 10 developed enterprises of
Urumqi were 1008 and 526, respectively. Trained staff
obtained the informed consent of all participants and car-
ried out interviews. A questionnaire on age, gender, ethni-
city, education level and residence was completed for all
subjects. Other characteristics, such as family number,
drinking, cigarette smoking and anthropometric measure-
ments, including height, weight, waistline and hip circum-
ference, were also recorded for all of the subjects in the
southern part of Xinjiang. All data were analyzed
anonymously. Body mass index (BMI) (kg/m
2)v a l u e sw e r e
also calculated for all subjects. Serum and plasma samples
were collected, separated immediately and stored at -80°C
prior to testing.
Sera were also collected from samples taken from 51
patients with classic KS registered during the period
between 1986 and 2008, at the First Teaching Hospital of
Xinjiang Medical University in Urumqi (age: 17-83 years,
4 5m a l ev s .6f e m a l e ,4 6U y g u rv s .5K a z a k h ,4 6f r o m
south region vs. 5 from other region of xinjiang), to com-
pare antibody titers with KSHV infected persons.The
study protocol was approved by the local research ethics
committee of the First Teaching Hospital of Xinjiang
Medical University. Written informed consents were
obtained from all study subjects before data collection.
Serological tests for KSHV
Three KSHV specific viral genes were expressed and puri-
fied as GST-fusion proteins used to construct the com-
bined antigens enzyme-linked immunosorbent assay
(ELISA) including latent antigen ORF73 and lytic antigens
ORF K8.1 and ORF65. Briefly, Viral antigens were diluted
in coating buffer to a final concentration of 10 μg/ml and
used to coat ELISA plates (Corning Glass Works, Corning,
NY, USA) overnight at 4°C. After washing with phosphate-
buffered saline (PBS) containing 0.05% Tween 20(PBST),
1:100 diluted serum samples were added and plates were
incubated for 60 min at 37°C. This was followed by incu-
bation with goat anti-human IgG conjugated with peroxi-
dase (Product No. A8667, Sigma, St. Louis, MO, USA) for
60 min at 37°C. The color reaction was developed for 15
min at RT with tetramethyl benzidine after PBST washing.
Reactions were stopped with 50 μlo f1MH 2SO4 and
absorbance was measured at a wavelength of 450 nm.
Serum samples from patients with classical-KS in Xinjiang
and with AIDS-KS or skin carcinoma in France which
were obtained from the Medical center of Besancon Uni-
versity France-Comte were used to assay the sensitivity
and specificity in this study. Based on the surveys of above
groups, the combined antigens ELISA had a sensitivity of
81.8% and specificity of 97.9%, respectively. In the follow-
ing screening, serum from an AIDS-KS patient that had
high antibody titers to both KSHV latent and lytic anti-
gens, and serum from three healthy children in Sichuan
province without any specific antibodies to KSHV, were
used as positive and negative controls, respectively, in all
assays. Both positive and negative controls were used in
three wells in each plate in this study. Each sample was
also tested three times. Based on the results of assays with
the control groups, a serum sample with an absorbance
value above the mean plus three standard deviations of the
negative control wells in an assay was considered as posi-
tive. A highly seropositive result for KSHV was set consid-
ered as a value greater than the mean absorbance value
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All assays were examined by a single observer.
Serum samples that were highly positive for antibodies
against KSHV in the ELISA assay and the sera of 51 KS
patients were analyzed to determine their antibodiy titers
using gradient serum dilutions (1:100,1:200,1:400,1:800,
1:1600 and 1:3200). The positive standard followed the cri-
terion above. Antibody titers lower than 1:400, between
1:400~1:800 and higher than 1:800 were classified into the
low group, medium and high group, respectively.
Statistical analysis
The data were entered in duplicate and analyzed using
the SPSS11.0 software (SPSS, Chicago, IL).Univariate
analysis was performed to examine associations between
the KSHV serostatus and all of the questionnaire vari-
ables. Factors that were significant in univariate analyses
at P = 0.100 were included in a multivariate logistic
regression analysis, to identify which factors, if any, were
independently associated with KSHV infection. Odds
ratios (ORs) and 95% confidence intervals (CIs) were
used to quantify the relationships, while P-values were
calculated to indicate the statistical significance. P-values
< 0.050 were considered significant. The chi-square test
was also performed when appropriate to compare anti-
body titers between KSHV -infected individuals and KS
patients.
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